Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Idec receives patent protection for radioimmunotherapy

June 3, 1998

Antisoma and Imperial Cancer Research Technology announce collaboration

May 27, 1998

Glaxo Wellcome's 3622W94: phase I trial results presented at ASCO

May 26, 1998

Pivotal trials of Allovectin-7 begin in advanced metastatic melanoma

May 26, 1998

MDX-210 shows significant antitumor activity in prostate and kidney cancer patients

May 22, 1998

97% response rate for Rituxan + CHOP in small pilot trial in intermediate- or high-grade NHL

May 21, 1998

Favorable preliminary phase I/II trials results reported at ASCO for Titan's cancer vaccines

May 21, 1998

GVAX induces immune responses in prostate cancer patients

May 21, 1998

Herceptin: promising phase III results reported at ASCO

May 20, 1998

Neurocrine Biosciences initiates clinical-stage development of IL-4 fusion toxin

May 19, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...